{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:45:26Z","timestamp":1792759526242,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1066-2","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T04:24:30Z","timestamp":1530591870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation"],"prefix":"10.1186","volume":"13","author":[{"given":"Christian","family":"Baues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Marnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Engert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Baus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Jablonska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Fogliata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"V\u00e1squez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"key":"1066_CR1","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/annonc\/mdh273","volume":"15","author":"K Behringer","year":"2004","unstructured":"Behringer K, Josting A, Schiller P, Eich HT, Bredenfeld H, Diehl V, et al. Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group. Ann Oncol. 2004;15:1079\u201385. Available from: \n                    https:\/\/academic.oup.com\/annonc\/article-lookup\/doi\/10.1093\/annonc\/mdh273\n                    \n                  .","journal-title":"Ann Oncol"},{"key":"1066_CR2","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1200\/JCO.2002.08.021","volume":"20","author":"AK Ng","year":"2002","unstructured":"Ng AK, Bernardo MP, Weller E, Backstrand KH, Silver B, Marcus KC, et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin\u2019s disease treated at age 50 or younger. J Clin Oncol. 2002;20:2101\u20138. Available from: \n                    http:\/\/ascopubs.org\/doi\/10.1200\/JCO.2002.08.021\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"1066_CR3","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","volume":"21","author":"BMP Aleman","year":"2003","unstructured":"Aleman BMP, van den Belt-Dusebout AW, Klokman WJ, Van't Veer MB, Bartelink H, van Leeuwen FE. Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin\u2019s Disease. J Clin Oncol. 2003;21:3431\u20139. Available from: \n                    http:\/\/ascopubs.org\/doi\/10.1200\/jco.2003.07.131\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"1066_CR4","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1093\/annonc\/mdt156","volume":"24","author":"MV Maraldo","year":"2013","unstructured":"Maraldo MV, Brodin NP, Aznar MC, Vogelius IR, Munck af Rosensch\u00f6ld P, Petersen PM, et al. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Ann Oncol. 2013;24:2113\u20138. Available from: \n                    https:\/\/academic.oup.com\/annonc\/article-lookup\/doi\/10.1093\/annonc\/mdt156\n                    \n                  .","journal-title":"Ann Oncol"},{"key":"1066_CR5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.ijrobp.2009.12.054","volume":"79","author":"W Machann","year":"2011","unstructured":"Machann W, Beer M, Breunig M, St\u00f6rk S, Angermann C, Seufert I, et al. Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 2011;79:1117\u201323. Available from: \n                    http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610000039\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1066_CR6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1200\/JCO.2009.25.2627","volume":"28","author":"S K\u00fcpeli","year":"2010","unstructured":"K\u00fcpeli S, Haz\u0131rolan T, Hazirolan T, Varan A, Akata D, Alehan D, et al. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma. J Clin Oncol. 2010;28:1025\u201330. Available from: \n                    http:\/\/ascopubs.org\/doi\/10.1200\/JCO.2009.25.2627\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"1066_CR7","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1200\/JCO.2013.54.4601","volume":"32","author":"CS Moskowitz","year":"2014","unstructured":"Moskowitz CS, Chou JF, Wolden SL, Bernstein JL, Malhotra J, Novetsky Friedman D, et al. Breast Cancer After Chest Radiation Therapy for Childhood Cancer. J Clin Oncol. 2014;32:2217\u201323. Available from: \n                    http:\/\/ascopubs.org\/doi\/10.1200\/JCO.2013.54.4601\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"1066_CR8","doi-asserted-by":"publisher","first-page":"E489","DOI":"10.1016\/j.ijrobp.2016.06.1858","volume":"96","author":"CC Pinnix","year":"2016","unstructured":"Pinnix CC, Abou Yehia Z, Smith GL, Milgrom SA, Ho JC, Reddy J, et al. More chemotherapy does not obviate the need for radiation therapy (RT): treatment for early-stage favorable Hodgkin lymphoma according to the HD10 trial compared with chemotherapy alone. Int J Radiat Oncol Biol Phys. 2016;96:E489\u201390. Available from: \n                    http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301616321848\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1066_CR9","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1056\/NEJMoa1408648","volume":"372","author":"J Radford","year":"2015","unstructured":"Radford J, Illidge T, Counsell N, Hancock B, Pettengell R, Johnson P, et al. Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin\u2019s Lymphoma. N Engl J Med. 2015;372:1598\u2013607. Available from: \n                    http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1408648\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1066_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1748-717X-9-94","volume":"9","author":"K Voong","year":"2014","unstructured":"Voong K, McSpadden K, Pinnix CC, Shihadeh F, Reed V, Salehpour MR, et al. Dosimetric advantages of a \u201cbutterfly\u201d technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin\u2019s lymphoma. Radiat Oncol. 2014;9:94\u20139.","journal-title":"Radiat Oncol"},{"key":"1066_CR11","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","volume":"89","author":"L Specht","year":"2014","unstructured":"Specht L, Yahalom J, Illidge T, et al. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys. 2014;89:854\u201362. Available from: \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2013.05.005\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1066_CR12","first-page":"1903","volume":"55","author":"M Oguchi","year":"2014","unstructured":"Oguchi M, Hasegawa M, Ishibashi N, Isobe K, Imai M, Ejima Y, et al. ILROG guideline of radiation therapy for nodal lymphomas: involved site radiation therapy. [Rinsho ketsueki] Jpn J Clin Hematol. 2014;55:1903\u201311. Available from: \n                    http:\/\/eutils.ncbi.nlm.nih.gov\/entrez\/eutils\/elink.fcgi?dbfrom=pubmed&id=25297754&retmode=ref&cmd=prlinks\n                    \n                  .","journal-title":"[Rinsho ketsueki] Jpn J Clin Hematol"},{"key":"1066_CR13","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1000067","volume":"363","author":"A Engert","year":"2010","unstructured":"Engert A, Pl\u00fctschow A, Eich HT, Lohri A, D\u00f6rken B, Borchmann P, et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J med. 2010;363:640\u201352. Available from: \n                    http:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJMoa1000067\n                    \n                  .","journal-title":"N Engl J med"},{"key":"1066_CR14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s00066-014-0719-9","volume":"190","author":"F Lohr","year":"2014","unstructured":"Lohr F, Georg D, Cozzi L, Eich HT, Weber DC, Koeck J, et al. Neue Strahlentherapietechniken f\u00fcr Involved-Field- und Involved-Node-Behandlung des mediastinalen Hodgkin-Lymphoms. Strahlenther Onkol. 2014;190:864\u201371. Available from: \n                    http:\/\/link.springer.com\/10.1007\/s00066-014-0719-9\n                    \n                  .","journal-title":"Strahlenther Onkol"},{"key":"1066_CR15","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1200\/JCO.2003.03.023","volume":"21","author":"A Engert","year":"2003","unstructured":"Engert A, Schiller P, Josting A, Herrmann R, Koch P, Sieber M, et al. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin\u2019s lymphoma: results of the HD8 trial of the German Hodgkin\u2019s lymphoma study group. J Clin Oncol. 2003;21:3601\u20138. Available from: \n                    http:\/\/ascopubs.org\/doi\/10.1200\/JCO.2003.03.023\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"1066_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.radonc.2013.07.013","volume":"109","author":"MH Verhappen","year":"2013","unstructured":"Verhappen MH, Poortmans PMP, Raaijmakers E, Raemaekers JMM. Reduction of the treated volume to involved node radiation therapy as part of combined modality treatment for early stage aggressive non-Hodgkin\u2019s lymphoma. Radiother Oncol. 2013;109:133\u20139. Available from: \n                    http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814013003885\n                    \n                  .","journal-title":"Radiother Oncol"},{"key":"1066_CR17","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ijrobp.2010.05.035","volume":"81","author":"DC Weber","year":"2011","unstructured":"Weber DC, Johanson S, Peguret N, Cozzi L, Olsen DR. Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage Hodgkin lymphoma in female patients. Int J Radiat Oncol Biol Phys. 2011;81:490\u20137. Available from: \n                    http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610007583\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1066_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ijrobp.2011.06.1959","volume":"83","author":"BS Hoppe","year":"2012","unstructured":"Hoppe BS, Flampouri S, Su Z, Morris CG, Latif N, Dang NH, et al. Consolidative involved-node proton therapy for stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary Dosimetric outcomes from a phase II study. Int J Radiat Oncol Biol Phys. 2012;83:260\u20137. Available from: \n                    http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301611028252\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1066_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ijrobp.2011.12.034","volume":"84","author":"BS Hoppe","year":"2012","unstructured":"Hoppe BS, Flampouri S, Su Z, Latif N, Dang NH, Lynch J, et al. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2012;84:449\u201355. Available from: \n                    http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301611037217\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1066_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijrobp.2015.02.030","volume":"92","author":"AR Filippi","year":"2015","unstructured":"Filippi AR, Ragona R, Piva C, Scafa D, Fiandra C, Fusella M, et al. Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk. Int J Radiat Oncol Biol Phys. 2015;92:161\u20138. Available from: \n                    http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301615002187\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1066_CR21","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.ijrobp.2008.12.048","volume":"75","author":"BS Chera","year":"2009","unstructured":"Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, et al. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys. 2009;75:1173\u201380. Available from: \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2008.12.048\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1066_CR22","doi-asserted-by":"publisher","first-page":"20150409","DOI":"10.1259\/bjr.20150409","volume":"89","author":"N Besson","year":"2016","unstructured":"Besson N, Pernin V, Zefkili S, Kirova YM. Evolution of radiation techniques in the treatment of mediastinal lymphoma: from 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): a single-centre experience and review of the literature. Br J Radiol. 2016;89:20150409\u20137. Available from: \n                    http:\/\/www.birpublications.org\/doi\/10.1259\/bjr.20150409\n                    \n                  .","journal-title":"Br J Radiol"},{"key":"1066_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijrobp.2015.01.013","volume":"92","author":"MC Aznar","year":"2015","unstructured":"Aznar MC, Maraldo MV, Schut DA, Lundemann M, Brodin NP, Vogelius IR, et al. Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both? Int J Radiat Oncol Biol Phys. 2015;92:169\u201374. Available from: \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.013\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1066_CR24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.ijrobp.2014.04.029","volume":"89","author":"BS Hoppe","year":"2014","unstructured":"Hoppe BS, Flampouri S, Zaiden R, Slayton W, Sandler E, Ozdemir S, et al. Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study. Int J Radiat Oncol Biol Phys. 2014;89:1053\u20139. Available from: \n                    http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301614005008\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1066_CR25","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1093\/annonc\/mdx287","volume":"28","author":"BS Hoppe","year":"2017","unstructured":"Hoppe BS, Hill-Kayser CE, Tseng YD, Flampouri S, Elmongy HM, Cahlon O, et al. Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma. Ann Oncol. 2017;28:2179\u201384. Available from: \n                    http:\/\/academic.oup.com\/annonc\/article\/doi\/10.1093\/annonc\/mdx287\/4082165\/Consolidative-proton-therapy-after-chemotherapy","journal-title":"Ann Oncol"},{"key":"1066_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijrobp.2010.05.007","volume":"81","author":"J Li","year":"2011","unstructured":"Li J, Dabaja B, Reed V, Allen PK, Cai H, Amin MV, et al. Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma. Int J Radiat Oncol Biol Phys. 2011;81:167\u201374. Available from: \n                    http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610006656","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1066_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1748-717X-8-184","volume":"8","author":"R Zhang","year":"2013","unstructured":"Zhang R, Howell RM, Homann K, Giebeler A, Taddei PJ, Mahajan A, et al. Predicted risks of radiogenic cardiac toxicity in two pediatric patients undergoing photon or proton radiotherapy. Radiat Oncol. 2013;8:184. Available from: \n                    http:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-8-184","journal-title":"Radiat Oncol"},{"key":"1066_CR28","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canrad.2015.11.002","volume":"20","author":"S Horn","year":"2016","unstructured":"Horn S, Fournier-Bidoz N, Pernin V, Peurien D, Vaillant M, Dendale R, et al. Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy. Cancer Radiother. 2016;20:98\u2013103. Available from: \n                    http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S127832181600038X\n                    \n                  .","journal-title":"Cancer Radiother"},{"key":"1066_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.radonc.2017.07.033","volume":"125","author":"LA Rechner","year":"2017","unstructured":"Rechner LA, Maraldo MV, Vogelius IR, Zhu XR, Dabaja BS, Brodin NP, et al. Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: the impact of proton therapy and\/or deep inspiration breath hold. Radiother Oncol. 2017;125:41\u20137.","journal-title":"Radiother Oncol"},{"key":"1066_CR30","doi-asserted-by":"publisher","first-page":"492","DOI":"10.14338\/IJPT-17-00012","volume":"3","author":"BS Hoppe","year":"2017","unstructured":"Hoppe BS, Mendenhall NP, Louis D, Li Z, Flampouri S. Comparing breath hold and free breathing during intensity-modulated radiation therapy and proton therapy in patients with mediastinal Hodgkin lymphoma. International Journal of Particle Therapy. 2017;3:492\u20136.","journal-title":"International Journal of Particle Therapy"},{"key":"1066_CR31","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1088\/0031-9155\/53\/4\/015","volume":"53","author":"AJ Lomax","year":"2008","unstructured":"Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions. Phys Med Biol. 2008;53:1043\u201356. Available from: \n                    http:\/\/stacks.iop.org\/0031-9155\/53\/i=4\/a=015?key=crossref.49a5dabe348f26645479f8d68643b59d","journal-title":"Phys Med Biol"},{"key":"1066_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s00066-008-1882-7","volume":"184","author":"HT Eich","year":"2008","unstructured":"Eich HT, M\u00fcller R-P, Engenhart-Cabillic R, Lukas P, Schmidberger H, et al. Involved-Node-Radiotherapie in fr\u00fchen Stadien des Hodgkin-Lymphoms. Definition und Richtlinien der Deutschen Hodgkin-Lymphom-Studiengruppe (GHSG). Strahlenther Onkol. 2008;184:406\u201310. Available from: \n                    http:\/\/link.springer.com\/10.1007\/s00066-008-1882-7","journal-title":"Strahlenther Onkol"},{"key":"1066_CR33","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1080\/0284186X.2016.1191665","volume":"55","author":"C Zeng","year":"2016","unstructured":"Zeng C, Plastaras JP, James P, Tochner ZA, Hill-Kayser CE, Hahn SM, et al. Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment. Acta Oncologica. 2016;55:1132\u20138.","journal-title":"Acta Oncologica"},{"key":"1066_CR34","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.ijrobp.2011.05.015","volume":"82","author":"A Paumier","year":"2012","unstructured":"Paumier A, APM D, MGM D, Ghalibafian M, Gilmore J, JGM D, et al. Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2012;82:1522\u20137. Available from: \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2011.05.015\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1066_CR35","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1200\/JCO.2008.20.2267","volume":"28","author":"M Tukenova","year":"2010","unstructured":"Tukenova M, Guibout C, Oberlin O, Doyon F, Mousannif A, Haddy N, et al. Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer. J Clin Oncol. 2010;28:1308\u201315. Available from: \n                    http:\/\/ascopubs.org\/doi\/10.1200\/JCO.2008.20.2267\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"1066_CR36","doi-asserted-by":"publisher","first-page":"b4606","DOI":"10.1136\/bmj.b4606","volume":"339","author":"DA Mulrooney","year":"2009","unstructured":"Mulrooney DA, Mulrooney DA, Yeazel MW, Yeazel MW, Kawashima T, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the childhood Cancer survivor study cohort. BMJ. 2009;339:b4606. Available from: \n                    http:\/\/www.bmj.com\/cgi\/doi\/10.1136\/bmj.b4606\n                    \n                  .","journal-title":"BMJ"},{"key":"1066_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.115.016686","volume":"133","author":"N Haddy","year":"2015","unstructured":"Haddy N, Diallo S, El-Fayech C, Schwartz B, Pein F, Hawkins M, et al. Cardiac Diseases Following Childhood Cancer Treatment CLINICAL PERSPECTIVE. Circulation. 2015;133:31\u20138. Available from: \n                    http:\/\/circ.ahajournals.org\/lookup\/doi\/10.1161\/CIRCULATIONAHA.115.016686\n                    \n                  .","journal-title":"Circulation"},{"key":"1066_CR38","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0959-8049(97)00056-7","volume":"33","author":"R Epstein","year":"1997","unstructured":"Epstein R, Hanham I, Dale R. Radiotherapy-induced second cancers: are we doing enough to protect young patients? Eur J Cancer (1990). 1997;33:526\u201330. Available from: \n                    http:\/\/eutils.ncbi.nlm.nih.gov\/entrez\/eutils\/elink.fcgi?dbfrom=pubmed&id=9274430&retmode=ref&cmd=prlinks\n                    \n                  .","journal-title":"Eur J Cancer (1990)"},{"key":"1066_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00066-002-0951-6","volume":"178","author":"W D\u00f6rr","year":"2002","unstructured":"D\u00f6rr W, Herrmann T. Second primary tumors after radiotherapy for malignancies. Treatment-related parameters. Strahlenther Onkol. 2002;178:357\u201362. Available from: \n                    http:\/\/eutils.ncbi.nlm.nih.gov\/entrez\/eutils\/elink.fcgi?dbfrom=pubmed&id=12163989&retmode=ref&cmd=prlinks\n                    \n                  .","journal-title":"Strahlenther Onkol"},{"key":"1066_CR40","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/jnci\/94.3.182","volume":"94","author":"LB Travis","year":"2002","unstructured":"Travis LB, Gospodarowicz M, Curtis RE, Clarke EA, Andersson M, Glimelius B, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst. 2002;94:182\u201392. Available from: \n                    http:\/\/eutils.ncbi.nlm.nih.gov\/entrez\/eutils\/elink.fcgi?dbfrom=pubmed&id=11830608&retmode=ref&cmd=prlinks\n                    \n                  .","journal-title":"J Natl Cancer Inst"},{"key":"1066_CR41","doi-asserted-by":"crossref","unstructured":"Meyer E, Goudjil F, Tamburini J, Dendale R, Kirova Y. Proton beam therapy for the management of mediastinal Hodgkin lymphoma in a young female patient. Cancer Radiother. 2018;","DOI":"10.1016\/j.canrad.2017.09.009"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1066-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1066-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1066-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T19:20:41Z","timestamp":1562095241000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1066-2"}},"subtitle":["A Planning Comparison Of Deep Inspiration Breath Hold Intensity Modulation Radiotherapy And Intensity Modulated Proton Therapy"],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1066"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1066-2","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"2 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. L. Cozzi acts as Scientific Advisor to Varian Medical Systems. Other authors have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"122"}}